HNGE - Company ID 0001673743
The table below shows Hinge Health, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $182.31M | $154.21M | $139.10M | $123.83M | $100.61M | $89.83M |
| Cost of revenue | $28.07M | $28.01M | $41.34M | $23.59M | $21.36M | $23.21M |
| Gross profit | $154.23M | $126.20M | $97.76M | $100.23M | $79.26M | $66.62M |
| R&D | $30.34M | $31.92M | $279.96M | $23.50M | $23.79M | $24.92M |
Hinge Health, Inc. reported annual revenue of $587.86M for fiscal year 2025. That is up 50.6% from $390.40M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A | $23.02M | $36.85M | $251.24M | $16.88M | $14.75M | $14.35M |
| Operating income | $32.07M | -$6.09M | -$580.67M | $13.14M | -$3.85M | -$17.55M |
| Income tax | $814.00K | $206.00K | -$326.00K | $998.00K | $1.11M | $361.00K |
| Net income | $35.13M | -$1.84M | -$575.65M | $17.14M | $341.00K | -$12.93M |
| EPS (diluted) | $0.41 | -$0.02 | -$13.10 | $1.31 | $0.01 | -$0.96 |